These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 18626311)

  • 1. Serum matrix metalloproteinase-8 is associated with ulceration and vascular invasion of malignant melanoma.
    Vihinen P; Koskivuo I; Syrjänen K; Tervahartiala T; Sorsa T; Pyrhönen S
    Melanoma Res; 2008 Aug; 18(4):268-73. PubMed ID: 18626311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High serum levels of matrix metalloproteinase-9 and matrix metalloproteinase-1 are associated with rapid progression in patients with metastatic melanoma.
    Nikkola J; Vihinen P; Vuoristo MS; Kellokumpu-Lehtinen P; Kähäri VM; Pyrhönen S
    Clin Cancer Res; 2005 Jul; 11(14):5158-66. PubMed ID: 16033831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and serum levels of MMP-2 and MMP-9 during human melanoma progression.
    Redondo P; Lloret P; Idoate M; Inoges S
    Clin Exp Dermatol; 2005 Sep; 30(5):541-5. PubMed ID: 16045689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical relevance of serum levels of matrix metallopeptidase-2, and tissue inhibitor of metalloproteinase-1 and -2 in patients with malignant melanoma.
    Yoshino Y; Kageshita T; Nakajima M; Funakubo M; Ihn H
    J Dermatol; 2008 Apr; 35(4):206-14. PubMed ID: 18419677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Survival analysis in patients with cutaneous malignant melanoma].
    Radović-Kovacević V; Pekmezović T; Adanja B; Jarebinski M; Marinković J; Tomin R
    Srp Arh Celok Lek; 1997; 125(5-6):132-7. PubMed ID: 9265233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix metalloproteinase-2 (72 kD type IV collagenase) expression occurs in the early stage of human melanocytic tumour progression and may have prognostic value.
    Väisänen A; Tuominen H; Kallioinen M; Turpeenniemi-Hujanen T
    J Pathol; 1996 Nov; 180(3):283-9. PubMed ID: 8958806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of MMP-2 immunoreactive protein (72 kD type IV collagenase) in primary skin melanoma.
    Väisänen A; Kallioinen M; Taskinen PJ; Turpeenniemi-Hujanen T
    J Pathol; 1998 Sep; 186(1):51-8. PubMed ID: 9875140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A retrospective histological study of 669 cases of primary cutaneous malignant melanoma in clinical stage I. 4. The relation of cross-sectional profile, level of invasion, ulceration and vascular invasion to tumour type and prognosis.
    Larsen TE; Grude TH
    Acta Pathol Microbiol Scand A; 1979 Mar; 87A(2):131-8. PubMed ID: 433595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the prognostic value of matrix metalloproteinases 2 and 9 in cutaneous melanoma.
    Väisänen AH; Kallioinen M; Turpeenniemi-Hujanen T
    Hum Pathol; 2008 Mar; 39(3):377-85. PubMed ID: 18187184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of activated matrix metalloproteinase-2 (MMP-2) as the main gelatinolytic enzyme in malignant melanoma by in situ zymography.
    Kurschat P; Wickenhauser C; Groth W; Krieg T; Mauch C
    J Pathol; 2002 Jun; 197(2):179-87. PubMed ID: 12015741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Highly sensitive multivariable assay detection of melanocytic differentiation antigens and angiogenesis biomarkers in sentinel lymph nodes with melanoma micrometastases.
    Vitoux D; Mourah S; Kerob D; Verola O; Basset-Seguin N; Baccard M; Schartz N; Ollivaud L; Archimbaud A; Servant JM; Revol M; Toubert ME; Podgorniak MP; Plassa F; Porcher R; Lebbé C
    Arch Dermatol; 2009 Oct; 145(10):1105-13. PubMed ID: 19841396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble interleukin-2 receptor in stage I-III melanoma.
    Ottaiano A; Leonardi E; Simeone E; Ascierto PA; Scala S; Calemma R; Bryce J; Caracò C; Satriano RA; Gianfranco N; Franco R; Botti G; Castello G
    Cytokine; 2006 Feb; 33(3):150-5. PubMed ID: 16517174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A retrospective histological study of 669 cases of primary cutaneous malignant melanoma in clinical stage I. 3. The relation between the tumour-associated lymphocyte infiltration and age and sex, tumour cell type, pigmentation, cellular atypia, mitotic count, depth of invasion, ulceration, tumour type and prognosis.
    Larsen TE; Grude TH
    Acta Pathol Microbiol Scand A; 1978 Nov; 86A(6):523-30. PubMed ID: 716913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acral lentiginous melanoma: histopathological prognostic features of 121 cases.
    Phan A; Touzet S; Dalle S; Ronger-Savlé S; Balme B; Thomas L
    Br J Dermatol; 2007 Aug; 157(2):311-8. PubMed ID: 17596173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic significance of tumor vascularity in intermediate-thickness (0.76-4.0 mm thick) skin melanoma. A quantitative histologic study.
    Srivastava A; Laidler P; Davies RP; Horgan K; Hughes LE
    Am J Pathol; 1988 Nov; 133(2):419-23. PubMed ID: 3189515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum VEGF-C is associated with metastatic site in patients with malignant melanoma.
    Vihinen PP; Hilli J; Vuoristo MS; Syrjänen KJ; Kähäri VM; Pyrhönen SO
    Acta Oncol; 2007; 46(5):678-84. PubMed ID: 17562445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel biomarkers in malignant melanoma.
    Bosserhoff AK
    Clin Chim Acta; 2006 May; 367(1-2):28-35. PubMed ID: 16480699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiopoietin-2 levels are associated with disease progression in metastatic malignant melanoma.
    Helfrich I; Edler L; Sucker A; Thomas M; Christian S; Schadendorf D; Augustin HG
    Clin Cancer Res; 2009 Feb; 15(4):1384-92. PubMed ID: 19228739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of the determination of serum markers in patients with malignant melanoma.
    Lugović L; Situm M; Buljan M; Poduje S; Sebetić K
    Coll Antropol; 2007 Jan; 31 Suppl 1():7-11. PubMed ID: 17469741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tenascin-C in primary malignant melanoma of the skin.
    Ilmonen S; Jahkola T; Turunen JP; Muhonen T; Asko-Seljavaara S
    Histopathology; 2004 Oct; 45(4):405-11. PubMed ID: 15469480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.